Dr. Tony Ting Chen, MD

Dr. Chen practices at Poway Surgery Center in Poway, California.

Dr. Chen's NPI, 1245684497, was assigned on April 13, 2016. Dr. Chen graduated from Duke University School Of Medicine in 2016. Dr. Chen holds California license A171188.

Dr. Chen's primary practice is Poway Surgery Center, at 15611 Pomerado Rd, Poway, CA 92064. The practice phone is (858) 521-0031.

Dr. Chen's primary practice is Poway Surgery Center in Poway, California. Dr. Chen is also affiliated with Palomar UC San Diego Health Poway. The medical group on file is Palomar Health Medical Group. Dmand AI also links Dr. Chen to 2 more hospitals, 2 home health agencies and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chen practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Chen's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Chen is board certified in urology by the American Board of Urology. Dmand AI has Dr. Chen's licenses on file in 2 states: California and Washington.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney removal surgery, kidney stone disease, urinary endoscopy and urine flow blockage among the conditions Dr. Chen treats.

CMS data shows 1,419 Medicare services from Dr. Chen across 13 procedure codes in 2024, for 405 Medicare patients. Medicare paid $117,195 for them.

CMS counts 405 Medicare patients who saw Dr. Chen in 2024. The largest group is 75 to 84, with 168 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Chen's median patient age at 70, with 29% women.

In 2024, Dr. Chen wrote 1,495 Medicare Part D claims for 450 patients. 82% of them were for generic drugs. CMS names the drug for 1,442 of them, across 17 drugs with 11 or more claims each, at $248,699 in total drug cost. In 2023, CMS named 650 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 0 out of 100 for Dr. Chen for performance year 2024, reported individually. Dr. Chen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chen as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 17 papers to Dr. Chen, published from 2015 to 2023. 2017 was the busiest year, with 4. The most frequent topics are Kidney Calculi, Ureteroscopy and Urinary Calculi. Dr. Chen has published most often in J Endourol. Dr. Chen's most frequent co-authors are Seth K. Bechis, MD, Roger Lu Sur, MD and Jonathan Henry Berger, MD.

CMS Open Payments shows 39 general payments to Dr. Chen from 14 drug and device companies from 2019 to 2025. Grants make up the largest share, 91% of the total. Boston Scientific Corporation paid the most, $25,381.

Dr. Chen graduated from Duke University School Of Medicine in 2016.

Dr. Chen is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.